Inventor · disambiguated record
Charles Cook
Also filed as: COOK CHARLES · COOK CHARLES M · COOK CHARLES MICHAEL
14 granted patents·6 pending applications·450 citations·filing 2000–2022
94Inventor score
Top patents by PatentIndex Score
20 records- 0197US6548477B1Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2000·Granted Apr 15, 2003·142 cites·52 claims
- 0296US7268111B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2005·Granted Sep 11, 2007·64 cites·44 claims
- 0395US7084108B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2001·Granted Aug 1, 2006·72 cites·27 claims
- 0492US7037890B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2001·Granted May 2, 2006·42 cites·59 claims
- 0591US7348307B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Granted Mar 25, 2008·9 cites·71 claims
- 0689US7432342B2Kinase anchor protein muteins, peptides thereof and related documentsSEQUENOM INC·Filed 2003·Granted Oct 7, 2008·40 cites·17 claims
- 0788US6919307B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2002·Granted Jul 19, 2005·26 cites·53 claims
- 0886US8598312B2Inhibitors of antigen presentation by MHC class II moleculesOLSON GARY LEE·Filed 2012·Granted Dec 3, 2013·8 cites·6 claims
- 0986US8222215B2Methods for the use of inhibitors of antigen presentation by MHC class II moleculesOLSON GARY LEE·Filed 2008·Granted Jul 17, 2012·9 cites·26 claims
- 1084US7105482B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2003·Granted Sep 12, 2006·14 cites·43 claims
- 1182US7405194B2Therapeutic agents and methods of use thereof for the treatment of melanomaPRAECIS PHARM INC·Filed 2006·Granted Jul 29, 2008·4 cites·71 claims
- 1279US7157420B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2004·Granted Jan 2, 2007·10 cites·46 claims
- 1375US7439231B2Inhibitors of antigen presentation by MHC class II molecules and methods of use thereofPROVID PHARMACEUTICALS INC·Filed 2004·Granted Oct 21, 2008·10 cites·10 claims
- 1461US2009156624A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2008·Application pending·0 cites
- 1557US2007117758A1Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 1656US2009155846A1Kinase anchor protein muteins, peptides thereof and related methodsSEQUENOM INC·Filed 2008·Application pending·0 cites
- 1752US2024254098A1Thioester prodrugs for the treatment of renal anomaliesALTIBIO INC·Filed 2022·Application pending·0 cites
- 1851US2011217324A1Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereofOLSON GARY L·Filed 2008·Application pending·0 cites
- 1946US2007161570A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 2039US8765802B2Kinase inhibitors, compositions thereof, and methods of use therewithSHOEMAKER ROBERT·Filed 2008·Granted Jul 1, 2014·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →